Cargando…

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features

BACKGROUND: The most prominent feature of melancholic depression is a near-total loss of the capacity to derive pleasure from activities or other positive stimuli. Additional symptoms can include psychomotor disturbances, anorexia, excessive guilt, and early awakening from sleep. Melancholic patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallinckrodt, Craig H, Watkin, John G, Liu, Chaofeng, Wohlreich, Madelaine M, Raskin, Joel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546184/ https://www.ncbi.nlm.nih.gov/pubmed/15631624 http://dx.doi.org/10.1186/1471-244X-5-1

Ejemplares similares

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials
por: Mallinckrodt, Craig H, et al.
Publicado: (2004)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
por: Wohlreich, Madelaine M, et al.
Publicado: (2004)

Disrupted Regional Homogeneity in Melancholic and Non-melancholic Major Depressive Disorder at Rest
por: Yan, Meiqi, et al.
Publicado: (2021)

Comparison of short-term (saliva) and long-term (hair) cortisol levels in out-patients with melancholic and non-melancholic major depression
por: Herane-Vives, Andrés, et al.
Publicado: (2020)

White Matter Network Disruption Is Associated With Melancholic Features in Major Depressive Disorder
por: He, Mengxin, et al.
Publicado: (2022)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Differentiating Melancholic and Non-melancholic Major Depressive Disorder Using Fractional Amplitude of Low-Frequency Fluctuations
por: Zhang, Yingying, et al.
Publicado: (2022)

Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials
por: Harada, Eiji, et al.
Publicado: (2015)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials
por: Micca, Joseph L, et al.
Publicado: (2013)

A COMPARISON OF MELANCHOLIC AND NONMELANCHOLIC RECURRENT MAJOR DEPRESSION IN HAN CHINESE WOMEN
por: Sun, Ning, et al.
Publicado: (2012)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

The Effect of Initial Duloxetine Dosing Strategy on Nausea in Korean Patients with Major Depressive Disorder
por: Lee, Min-Soo, et al.
Publicado: (2012)

Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions
por: Gili, Margalida, et al.
Publicado: (2012)

Duloxetine 60 mg once daily in the treatment of milder major depressive disorder
por: Perahia, DGS, et al.
Publicado: (2006)

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
por: Wise, T N, et al.
Publicado: (2007)

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial
por: Arnold, Lesley M, et al.
Publicado: (2011)

Electroencephalographic Parameters Differentiating Melancholic Depression, Non-melancholic Depression, and Healthy Controls. A Systematic Review
por: Bruun, Caroline Fussing, et al.
Publicado: (2021)

Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol
por: Monzón, Saray, et al.
Publicado: (2010)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with the Melancholic Subtype of Major Depressive Disorder in China
por: Xiang, Yu-Tao, et al.
Publicado: (2012)

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
por: Harada, E, et al.
Publicado: (2015)

Shakespeare's Melancholics
por: Tredgold, R. F.
Publicado: (1964)

Cerebrospinal Fluid Space Alterations in Melancholic Depression
por: Via, Esther, et al.
Publicado: (2012)

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials
por: Choy, Ernest H. S., et al.
Publicado: (2009)

Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants
por: Ichikawa, Naho, et al.
Publicado: (2020)

Abnormal Default-Mode Network Homogeneity in Melancholic and Nonmelancholic Major Depressive Disorder at Rest
por: Yan, Meiqi, et al.
Publicado: (2021)

The aberrant dynamic amplitude of low-frequency fluctuations in melancholic major depressive disorder with insomnia
por: Deng, Zijing, et al.
Publicado: (2022)

Melancholic and reactive depression: a reappraisal of old categories
por: Mizushima, Jin, et al.
Publicado: (2013)

Heterogeneity in major depression and its melancholic and atypical specifiers: a secondary analysis of STAR*D
por: Lorenzo-Luaces, Lorenzo, et al.
Publicado: (2021)

Attributes of response in depressed patients switched to treatment with duloxetine
por: Sagman, D, et al.
Publicado: (2011)

Increased telomerase activity in major depressive disorder with melancholic features: Possible role of pro-inflammatory cytokines and the brain-derived neurotrophic factor
por: Bürhan-Çavuşoğlu, Pınar, et al.
Publicado: (2021)

Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder
por: Lu, Yun-Rong, et al.
Publicado: (2014)

Publisher Correction: Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants
por: Ichikawa, Naho, et al.
Publicado: (2020)

Impact of dysfunctional parenting, affective temperaments, and stressful life events on the development of melancholic and non-melancholic depression: A path analysis study
por: Tamada, Yu, et al.
Publicado: (2023)

Bias and discriminability during emotional signal detection in melancholic depression
por: Hyett, Matthew, et al.
Publicado: (2014)

Dietary Patterns Are Differentially Associated with Atypical and Melancholic Subtypes of Depression
por: Lasserre, Aurélie M., et al.
Publicado: (2021)

Six Cases of Melancholic Stupor
por: Ewens, E. F. W.
Publicado: (1902)

Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2011)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
por: Norman, Trevor R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rhhkpdbp2gqt27v0n6enatj026